SANGUISORBA OFFICINALIS LINNE EXTRACT COMPOSITION INHIBITING 3CL PROTEASE AND RDRP ACTIVITY OF SARS-COV-2

Abstract: the present invention relates to a use of a novel linne extract to inhibit sars-cov-2 virus 3cl protease and rdrp activity. the composition including the linne extract of the present invention as an active ingredient inhibits 3cl protease and rdrp activity and thus is effective in preventing or treating infection by sars-cov-2 and a variant virus thereof.

Inventor(s): Mun Seog CHANG, Tae Hee LEE, Min Ji LEE, Seung Jae LEE, Ha Young KIM, Jung Bin MIN, Ji Hye PARK, Won Hyung CHOI, Wook Ha PARK

CPC Classification: A61K36/739 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250177469